Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Whitepaper on...

    Whitepaper on E-pharmacies released

    Written by savita thakur thakur Published On 2016-07-26T13:08:49+05:30  |  Updated On 26 July 2016 1:08 PM IST
    Whitepaper on E-pharmacies released

    New Delhi : The Federation of Indian Chambers of Commerce and Industry (FICCI) an apex business organization in association with Frost & Sullivan, a leading growth and strategy consulting firm, announced the launch of a whitepaper titled ‘‘e-Pharmacy in India Last Mile Access of Medicines” in the presence of Government dignitaries and the concerned stakeholders on July 25th, 2016 at New Delhi.


    The whitepaper was released by Shri K. B. Aggarwal, Additional Secretary (Food and Drugs), and Ministry of Health & Family Welfare.


    The launch was followed by an intense panel discussion on the importance of the concept of e-Pharmacies and the deliberations on the need of guidelines/policies to ensure legitimate players delivering the benefits of the model to consumers, thereby, enabling wider access to medicines and improving public health. The panel’s participants included officials from the Ministry of Health & Family Welfare, Central Drugs Standard Control Organization, World Health Organization (WHO), and consumer activists. The event witnessed an engaging discussion between the concerned stakeholders of the Government as well as the industry.


    The whitepaper highlighted the need for improving access to quality medicines to even the remotest part of the country in order to address the key challenges in India growing population, changing lifestyles, and increasing health hazards.


    Frost & Sullivan prepared the whitepaper post exhaustive research and consultation with various stakeholders along with inputs from FICCI. Commenting on the event, Dr. Suhasini M., Consultant, Transformational Health (Healthcare) Practice, Frost & Sullivan, said, “Conditions like diabetes, hypertension, obesity, etc. require patients to regularly use medications. Poor adherence to medical treatment not only compromises patient’s health but also increases mortality, thereby impacting the economic growth of the country. Access to medicines remains a key challenge in India, which is primarily driven by unequal distribution of pharmacies in urban and rural India and inability of retail pharmacies to store a wide range of products, forcing consumers to visit multiple stores for procuring all the required medicines.”


    She further highlighted, “With the use of technology and access to inventory of multiple stores at a time, e-Pharmacies can aggregate supplies, making otherwise hard to find medicines available to consumers across the country.”


    The objective of this whitepaper is to understand the benefits of the e-Pharmacy model for the consumers, the industry, and the nation, and analyze its challenges and the policy level changes needed to address the concerns around the model.

    Central Drugs Standard Control OrganizationDr Suhasini Me-pharmacyFederation of Indian Chambers of Commerce and IndustryFiccigrowthMinistry of Health & Family WelfareShri K B AggarwalWHOWorld Health Organization
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok